These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 15894454)

  • 1. The prognostic role of the sentinel lymph node in clinically node-negative patients with cutaneous melanoma: experience of the Genoa group.
    Gipponi M; Solari N; Lionetto R; Di Somma C; Villa G; Schenone F; Queirolo P; Cafiero F
    Eur J Surg Oncol; 2005 Dec; 31(10):1191-7. PubMed ID: 15894454
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sentinel lymph node biopsy in patients with Stage I/II melanoma: Clinical experience and literature review.
    Gipponi M; Di Somma C; Peressini A; Solari N; Gliori S; Nicolo G; Schenone F; Queirolo P; Sertoli MR; Cafiero F
    J Surg Oncol; 2004 Mar; 85(3):133-40. PubMed ID: 14991885
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sentinel lymph node as a new marker for therapeutic planning in breast cancer patients.
    Gipponi M; Bassetti C; Canavese G; Catturich A; Di Somma C; Vecchio C; Nicolò G; Schenone F; Tomei D; Cafiero F
    J Surg Oncol; 2004 Mar; 85(3):102-11. PubMed ID: 14991881
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Prognosis after sentinel node biopsy in malignant melanoma].
    Lock-Andersen J; Horn J; Sjøstrand H
    Ugeskr Laeger; 2006 Jun; 168(25):2457-62. PubMed ID: 16824370
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sentinel node identification by scintigraphic methods in cutaneous melanoma.
    Dias Moreira R; Altino de Almeida S; Maliska Guimarães CM; Resende JF; Gutfilen B; Barbosa da Fonseca LM
    J Exp Clin Cancer Res; 2005 Jun; 24(2):181-5. PubMed ID: 16110749
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The sentinel lymph node status is an important factor for predicting clinical outcome in patients with Stage I or II cutaneous melanoma.
    Statius Muller MG; van Leeuwen PA; de Lange-De Klerk ES; van Diest PJ; Pijpers R; Ferwerda CC; Vuylsteke RJ; Meijer S
    Cancer; 2001 Jun; 91(12):2401-8. PubMed ID: 11413531
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Sentinel lymph node biopsy for melanoma: prognostic value and disadvantages in 300 patients].
    de Vries M; Jager PL; Suurmeijer AJ; Plukker JT; van Ginkel RJ; Hoekstra HJ
    Ned Tijdschr Geneeskd; 2005 Aug; 149(33):1845-51. PubMed ID: 16128183
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High positive sentinel node identification rate by EORTC melanoma group protocol. Prognostic indicators of metastatic patterns after sentinel node biopsy in melanoma.
    van Akkooi AC; de Wilt JH; Verhoef C; Graveland WJ; van Geel AN; Kliffen M; Eggermont AM
    Eur J Cancer; 2006 Feb; 42(3):372-80. PubMed ID: 16403622
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Important prognostic significance of a sentinel-node biopsy in patients with malignant melanoma].
    Keijzer R; Bril H; van der Loo EM; de Graaf PW
    Ned Tijdschr Geneeskd; 2004 May; 148(18):884-8. PubMed ID: 15152391
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Survival analysis and clinicopathological factors associated with false-negative sentinel lymph node biopsy findings in patients with cutaneous melanoma.
    Nowecki ZI; Rutkowski P; Nasierowska-Guttmejer A; Ruka W
    Ann Surg Oncol; 2006 Dec; 13(12):1655-63. PubMed ID: 17016755
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical applications of sentinel lymph-node biopsy for the staging and treatment of solid neoplasms.
    Gipponi M
    Minerva Chir; 2005 Aug; 60(4):217-33. PubMed ID: 16166921
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic value of sentinel node biopsy in 327 prospective melanoma patients from a single institution.
    Roulin D; Matter M; Bady P; Liénard D; Gugerli O; Boubaker A; Bron L; Lejeune FJ
    Eur J Surg Oncol; 2008 Jun; 34(6):673-9. PubMed ID: 17825518
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sentinel node status in melanoma patients is not predictive for overall survival upon multivariate analysis.
    Roka F; Kittler H; Cauzig P; Hoeller C; Hinterhuber G; Wolff K; Pehamberger H; Diem E
    Br J Cancer; 2005 Feb; 92(4):662-7. PubMed ID: 15700039
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multivariable analysis comparing outcome after sentinel node biopsy or therapeutic lymph node dissection in patients with melanoma.
    van Akkooi AC; Bouwhuis MG; de Wilt JH; Kliffen M; Schmitz PI; Eggermont AM
    Br J Surg; 2007 Oct; 94(10):1293-9. PubMed ID: 17702089
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sentinel lymph node biopsy in cutaneous melanoma: a case-control study.
    Koskivuo I; Talve L; Vihinen P; Mäki M; Vahlberg T; Suominen E
    Ann Surg Oncol; 2007 Dec; 14(12):3566-74. PubMed ID: 17924169
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sentinel lymph node biopsy in cutaneous melanoma: outcome after 5-years follow-up.
    Cuchet E; Pinel N; Corcella D; Vuillez JP; Lebeau J; Moutet F; Colonna M; Leccia MT
    Eur J Dermatol; 2007; 17(5):387-91. PubMed ID: 17673381
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sentinel lymph node biopsy in melanoma patients: the medical oncologist's perspective.
    Queirolo P; Taveggia P; Gipponi M; Sertoli MR
    J Surg Oncol; 2004 Mar; 85(3):162-5. PubMed ID: 14991888
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Isolated tumor cells in the sentinel node affect long-term prognosis of patients with melanoma.
    Scheri RP; Essner R; Turner RR; Ye X; Morton DL
    Ann Surg Oncol; 2007 Oct; 14(10):2861-6. PubMed ID: 17882497
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of sentinel lymph node biopsy in patients with local recurrence or in-transit metastasis of melanoma.
    Gipponi M; Solari N; Giovinazzo D; Queirolo P; Bertoglio S; Villa G; Gualco M; Bleidl D; Cafiero F
    Anticancer Res; 2014 Jun; 34(6):3197-203. PubMed ID: 24922694
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The survival benefit to patients with positive sentinel node melanoma after completion lymph node dissection may be limited to the subgroup with a primary lesion Breslow thickness greater than 1.0 and less than or equal to 4 mm (pT2-pT3).
    Nowecki ZI; Rutkowski P; Michej W
    Ann Surg Oncol; 2008 Aug; 15(8):2223-34. PubMed ID: 18506535
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.